Mylan announced it would start selling a generic version of its EpiPen for $300 per two-pack this week.
The Canonsburg, Pa.-based pharma company will offer the generic epinephrine auto-injectors for 50% less than EpiPen’s $608 list price.
“Americans are rightfully concerned about rising drug prices, and now more than ever patients and families across this country are standing at the pharmacy counter struggling to pay for their medications. While it is important to understand the outdated and complex system that determines what someone pays for medicine in the U.S., hardworking families don’t need an explanation, they need a solution. This is why we took decisive action with our EpiPen product and have launched the first generic version at half the WAC price. This unprecedented action, along with the enhancements we made to our patient access programs, will help patients and provide substantial savings to payors,” said Heather Bresch, CEO, Mylan.
As Reuters noted, the company has been under intense scrutiny lately due to raising the price of a pair of EpiPens to more than $600 from $100 in 2008. CEO Bresch had to testify before Congress earlier this year on the price increase.